Stockreport

Liberate Bio gains licences for myeloid-specific CAR design patents [Yahoo! Finance]

Carisma Therapeutics, Inc.  (CARM) 
PDF Liberate Bio has obtained both exclusive and non-exclusive licences for patents related to chimeric antigen receptor (CAR) designs tailored for myeloid cells, such as m [Read more]